Development of an in vitro model of hereditary tyrosinemia type 1 using patient-derived induced pluripotent stem cells. Issue 4 (October 2017) - Pham, Q.T.; M'Callum, M.; Waters, P.; Halac, U.; Raad, S.; Mangahas, C.; Raggi, C.; Paganelli, M.